From: External validation of an opioid misuse machine learning classifier in hospitalized adult patients
Characteristics and outcomes | Opioid misuse (n = 628) | No misuse (n = 53467) | p-value |
---|---|---|---|
Age, median (IQR) | 49 (38–8) | 61 (45–71) |  < 0.001 |
Male Sex, n (%) | 400 (63.6%) | 22055 (41.2%) |  < 0.001 |
Race/Ethnicity, n (%) |  < 0.001 | ||
 Non-Hispanic White | 196 (31.2%) | 23221 (43.4%) | |
 Non-Hispanic Black | 336 (53.5%) | 17232 (32.2%) | |
 Hispanic White | 26 (4.1%) | 2927 (5.5%) | |
 Hispanic Black | 2 (< 1%) | 134 (< 1%) | |
 Other | 68 (10.8%) | 9953 (18.6%) | |
DAST Score (median, IQR, n = 16,453) | 6 (4–8) | 0 (0–1) |  < 0.001 |
Insurance, n (%) |  < 0.001 | ||
 Medicare | 79 (12.5%) | 20074 (37.5%) | |
 Medicaid | 65 (74.0%) | 18136 (33.9%) | |
 Private | 84 (13.4%) | 14686 (27.4%) | |
 Other | 0 (0%) | 571 (1.1%) | |
Elixhauser Comorbidities, n (%) | |||
 Hypertension, uncomplicated | 163 (25.9%) | 17686 (33.1%) |  < 0.001 |
 Hypertension, complicated | 150 (23.8%) | 14970 (27.9%) | 0.025 |
 Diabetes Mellitus, uncomplicated | 25 (3.9%) | 3718 (6.9%) | 0.005 |
 Diabetes Mellitus, complicated | 83 (13.2%) | 11277 (21.1%) |  < 0.001 |
 Renal Failure | 93 (14.8%) | 11045 (20.7%) |  < 0.001 |
 Neurologic Disorders | 100 (15.9%) | 8471 (15.8%) | 0.999 |
 Congestive Heart Failure | 117 (18.6%) | 9670 (18.1%) | 0.764 |
 Liver Disease | 94 (14.9%) | 3772 (7.1%) |  < 0.001 |
 Chronic Lung Disease | 236 (37.5%) | 10633 (19.9%) |  < 0.001 |
 Psychoses | 119 (18.9%) | 2072 (3.8%) |  < 0.001 |
 Depression | 146 (23.2%) | 7974 (14.9%) |  < 0.001 |
 Alcohol Abuse | 116 (18.4%) | 1957 (3.6%) |  < 0.001 |
 Drug Abuse | 605 (96.3%) | 1190 (2.2%) |  < 0.001 |
 AIDS/HIV | 22 (3.5%) | 389 (< 1%) |  < 0.001 |
Discharge Disposition, n (%) |  < 0.001 | ||
 Home | 355 (56.5%) | 31224 (57.1%) | |
 In-Hospital Death | 3 (< 1%) | 590 (1.1%) | |
 Long or Shorter Term Care | 120 (19.1%) | 7150 (13.4%) | |
 Against Medical Advice | 60 (9.5%) | 365 (< 1%) | |
 Other | 90 (14.3%) | 14138 (26.4%) |